Timothy Padot

Array ( [id] => 6658301 [patent_doc_number] => 20030133931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Use of histamine H4 receptor antagonist for the treatment of inflammatory responses' [patent_app_type] => new [patent_app_number] => 10/036648 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8855 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133931.pdf [firstpage_image] =>[orig_patent_app_number] => 10036648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728023 [patent_doc_number] => 07041475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Purified and isolated platelet calcium channel nucleic acids' [patent_app_type] => utility [patent_app_number] => 10/029413 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 35481 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041475.pdf [firstpage_image] =>[orig_patent_app_number] => 10029413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958728 [patent_doc_number] => 06953673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-11 [patent_title] => 'Histamine H2 receptor and uses' [patent_app_type] => utility [patent_app_number] => 10/017393 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16920 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953673.pdf [firstpage_image] =>[orig_patent_app_number] => 10017393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6260144 [patent_doc_number] => 20020187524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => '8099, 46455, 54414, 53763, 67076, 67102, 44181, 67084FL, and 67084 alt, human proteins and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/024623 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 79 [patent_no_of_words] => 76068 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187524.pdf [firstpage_image] =>[orig_patent_app_number] => 10024623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859817 [patent_doc_number] => 20020123454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'NT69, a novel nucleoside transporter family member and uses therefor' [patent_app_type] => new [patent_app_number] => 10/023673 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 36572 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123454.pdf [firstpage_image] =>[orig_patent_app_number] => 10023673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131328 [patent_doc_number] => 20020077297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'High-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels' [patent_app_type] => new [patent_app_number] => 09/989797 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3733 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077297.pdf [firstpage_image] =>[orig_patent_app_number] => 09989797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844222 [patent_doc_number] => 20020132252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/990442 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 331 [patent_figures_cnt] => 331 [patent_no_of_words] => 291078 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132252.pdf [firstpage_image] =>[orig_patent_app_number] => 09990442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655465 [patent_doc_number] => 20030077594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/993583 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 331 [patent_figures_cnt] => 331 [patent_no_of_words] => 290819 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077594.pdf [firstpage_image] =>[orig_patent_app_number] => 09993583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405835 [patent_doc_number] => 20020182635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Methods of screening for LTRPC2 modulators' [patent_app_type] => new [patent_app_number] => 10/007706 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14473 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182635.pdf [firstpage_image] =>[orig_patent_app_number] => 10007706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5789468 [patent_doc_number] => 20020161194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Cannine androgen receptor' [patent_app_type] => new [patent_app_number] => 10/008739 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8694 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161194.pdf [firstpage_image] =>[orig_patent_app_number] => 10008739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537517 [patent_doc_number] => 20020137168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Developmental tyrosine kinases and their ligands' [patent_app_type] => new [patent_app_number] => 09/985675 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10681 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137168.pdf [firstpage_image] =>[orig_patent_app_number] => 09985675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467886 [patent_doc_number] => 20020151011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Fusion polypeptides of human serum albumin and a therapeutically active polypeptide' [patent_app_type] => new [patent_app_number] => 09/984186 [patent_app_country] => US [patent_app_date] => 2001-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12567 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151011.pdf [firstpage_image] =>[orig_patent_app_number] => 09984186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6181995 [patent_doc_number] => 20020157120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Circularly permuted fluorescent protein indicators' [patent_app_type] => new [patent_app_number] => 09/999745 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23503 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20020157120.pdf [firstpage_image] =>[orig_patent_app_number] => 09999745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958743 [patent_doc_number] => 06953688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-11 [patent_title] => 'Vector for screening for modulators of IgE synthesis, secretion and switch rearrangement' [patent_app_type] => utility [patent_app_number] => 09/966976 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 34 [patent_no_of_words] => 20473 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953688.pdf [firstpage_image] =>[orig_patent_app_number] => 09966976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730170 [patent_doc_number] => 20030186360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune -and colon-related tissues' [patent_app_type] => new [patent_app_number] => 09/964821 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 38753 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186360.pdf [firstpage_image] =>[orig_patent_app_number] => 09964821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728001 [patent_doc_number] => 07041467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement' [patent_app_type] => utility [patent_app_number] => 09/963206 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 34 [patent_no_of_words] => 20469 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041467.pdf [firstpage_image] =>[orig_patent_app_number] => 09963206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692547 [patent_doc_number] => 20030039979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Association of beta2-adrenergic receptor haplotypes with drug response' [patent_app_type] => new [patent_app_number] => 09/954292 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20194 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039979.pdf [firstpage_image] =>[orig_patent_app_number] => 09954292 [rel_patent_id] =>[rel_patent_doc_number] =>)